Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46001071BKPyvENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS46001465BKPyvENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10017814HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10038012HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS10033573HBVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30008064HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30003350HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30008065HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30019504HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TVIS30054554HIVENSG00000142166.15protein_codingIFNAR1NoNo3454P17181
TCGA Plot Options
Drug Information
GeneIFNAR1
DrugBank IDDB00060
Drug NameInterferon beta-1a
Target IDBE0000661
UniProt IDP17181
Regulation Typeagonist
PubMed IDs10049744; 16912135; 12034032; 11747625
CitationsRussell-Harde D, Wagner TC, Perez HD, Croze E: Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Biochem Biophys Res Commun. 1999 Feb 16;255(2):539-44.@@van Koetsveld PM, Vitale G, de Herder WW, Feelders RA, van der Wansem K, Waaijers M, van Eijck CH, Speel EJ, Croze E, van der Lely AJ, Lamberts SW, Hofland LJ: Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth. J Clin Endocrinol Metab. 2006 Nov;91(11):4537-43. Epub 2006 Aug 15.@@Dupont SA, Goelz S, Goyal J, Green M: Mechanisms for regulation of cellular responsiveness to human IFN-beta1a. J Interferon Cytokine Res. 2002 Apr;22(4):491-501.@@Runkel L, De Dios C, Karpusas M, Baker D, Li Z, Zafari M, Betzenhauser M, Muldowney C, Miller S, Redlich PN, Grossberg SE, Whitty A, Hochman PS: Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis. J Interferon Cytokine Res. 2001 Nov;21(11):931-41.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKBPA450037
ChEMBLCHEMBL1201562